Goldman Sachs’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,800
Closed -$1.46M 5640
2018
Q3
$1.46M Buy
+12,800
New +$1.45M ﹤0.01% 3803
2017
Q2
Sell
-50,000
Closed -$3.47M 6962
2017
Q1
$3.47M Hold
50,000
﹤0.01% 3240
2016
Q4
$3.37M Sell
50,000
-11,600
-19% -$787K ﹤0.01% 3400
2016
Q3
$4.5M Hold
61,600
﹤0.01% 3129
2016
Q2
$4.24M Hold
61,600
﹤0.01% 2995
2016
Q1
$4.38M Hold
61,600
﹤0.01% 2824
2015
Q4
$4.64M Buy
+61,600
New +$4.45M ﹤0.01% 2895
2015
Q2
Sell
-55,000
Closed -$3.87M 7427
2015
Q1
$3.87M Sell
55,000
-55,000
-50% -$3.63M ﹤0.01% 3138
2014
Q4
$7.13M Buy
+110,000
New +$6.79M ﹤0.01% 2648

Other funds holding STE

Goldman Sachs's STE Position: Q1 2026 in Review

Goldman Sachs reduced its Steris (STE) stake by 40% in Q1 2026, selling an estimated $62.1M and leaving 381,577 shares worth $84.4M. The position accounts for 0.01% of the portfolio, ranked #1160.

Goldman Sachs first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $161M in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Goldman Sachs held 381,577 shares of Steris worth $84.4M as of Q1 2026.
  • Goldman Sachs sold 253,720 Steris shares in Q1 2026, an estimated $62.1M.
  • Steris made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1160 holding.
  • Goldman Sachs first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Steris position peaked at $161M in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.